Hi,
https://www.einnews.com/pr_news/5564526 ... ogy-trends
"SEATTLE, WASHINGTON, UNITED STATES, November 16, 2021 /EINPresswire.com/ -- The increasing research and development activities and funding by various organizations for the development of monovaccine are expected to drive the market growth over the forecast period. Currently, there is no licensed vaccine for Epstein-Barr Virus (EBV). However, various universities and organizations are focusing on developing novel vaccines against EBV and cater to the unmet needs."...
...."Several government organizations from different regions are focusing on the development of novel monovaccines (Epstein - Barr virus) and also focuses on gaining approval from regulatory authorities. For instance, in 2019, researchers from the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) determined how various antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory...."
Monovaccine (Epstein - Barr virus) Market Overview 2021
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2279 Views
-
Last post by NHE
-
- 1 Replies
- 266 Views
-
Last post by Leonard
-
- 2 Replies
- 839 Views
-
Last post by DIM
-
- 0 Replies
- 1847 Views
-
Last post by Tif
-
- 0 Replies
- 1625 Views
-
Last post by Tif
-
- 0 Replies
- 1395 Views
-
Last post by Tif
-
- 1 Replies
- 1096 Views
-
Last post by 1eye
-
- 0 Replies
- 1234 Views
-
Last post by frodo
-
- 2 Replies
- 2034 Views
-
Last post by Scott1